Other

FDA approves Botox competitor that lasts longer

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.

Diseases, Conditions, Syndromes

No benefit in common shoulder treatment over placebo, finds study

A saline injection treatment widely used for calcific tendinopathy—a common, painful condition caused by a build-up of calcium in the rotator cuff tendons of the shoulder—provides no meaningful benefit over placebo, concludes ...

Oncology & Cancer

Risk of side effects from cancer immunotherapy linked to genetics

Even as they've revolutionized cancer treatment, drugs known as immune checkpoint inhibitors can produce a range of adverse, immune-related side effects. In a new study, scientists at Dana-Farber Cancer Institute identify, ...

page 5 from 25